Concurrent chemoradiotherapy with nedaplatin after radical hysterectomy in patients with stage IB and II cervical cancer

Journal of Obstetrics and Gynaecology Research

Volumn 35, Issue 3, 2009, Pages 490-494

  Kobayashi, Yoichi ^a   Ohara, Tatsuru ^a   Wada, Yasuna ^a   Okuda, Yoshiko ^a   Kondo, Haruhiro ^a   Okuma, Yoshiaki ^a   Suzuki, Nao ^a   Gomi, Hiromichi ^b   Kiguchi, Kazushige ^a   Ishizuka, Bunpei ^a  

^a Department of Obstetrics and Gynecology ^*  (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cervical cancer; Concurrent chemoradiotherapy; Nedaplatin; Radical hysterectomy

Indexed keywords

NEDAPLATIN;

ADULT; ARTICLE; BONE MARROW SUPPRESSION; CANCER INVASION; CANCER RISK; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG EFFICACY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FEVER; GROUPS BY AGE; HIGH RISK PATIENT; HUMAN; LYMPH NODE; LYMPHOCYTIC INFILTRATION; MULTIMODALITY CANCER THERAPY; NEUTROPENIA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE CARE; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADICAL HYSTERECTOMY; RETROSPECTIVE STUDY; THROMBOCYTOPENIA; UTERINE CERVIX CANCER;

ADULT; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 67650495549     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2008.00955.x     Document Type: Article

References (18)

1. Grisaru DA, Covens A, Franssen E et al. Histopathologic score predicts recurrence free survival after radical surgery in patients with stage ia2-ib1-2 cervical carcinoma. Cancer 2003 97 : 1904 1908. (Pubitemid 36397264)
2. Metindir J, Birir G. Prognostic factors affecting disease-free survival in early-stage cervical cancer patients undergoing radical hysterectomy and pelvic-paraaortic lymphadenectomy. Eur J Gynaecol Oncol 2007 28 : 28 32. (Pubitemid 46408227)
3. Uno T, Ito H, Itami J et al. Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors. Anticancer Res 2000 20 : 2235 2239. (Pubitemid 30636215)
4. Koshiyama M, Kinezaki M, Uchida T, Sumitomo M. Chemosensitivity testing of a novel platinum analog, nedaplatin (254-S), in human gynecological carcinomas: A comparison with cisplatin. Anticancer Res 2005 25 : 4499 4502. (Pubitemid 41729503)
5. Kodama J, Takemoto M, Seki N et al. Phase I study of weekly nedaplatin and concurrent pelvic radiotherapy as adjuvant therapy after radical surgery for cervical cancer. Int J Gynecol Cancer 2007 18 : 1037 1041 doi: 10.1111/j.1525-1438.2008.01199.x.
6. Grigsby PW, Herzog TJ. Current management of patients with invasive cervical carcinoma. Clin Obstet Gynecol 2001 44 : 531 537. (Pubitemid 32751774)
7. Aoki Y, Sasaki M, Watanabe M et al. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Gynecol Oncol 2000 77 : 305 309. (Pubitemid 30317154)
8. Rose PG, Bundy BN, Watkins EB et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999 341 : 696 697.
9. Whitney CW, Sause W, Bundy BN et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest oncology Group study. J Clin Oncol 1999 17 : 1339 1348. (Pubitemid 29220838)
10. Peters WA III., Liu PY, Barrett RJ II. et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000 18 : 1606 1613. (Pubitemid 30220538)
11. Ryu HS, Chun M, Chang KH, Chang HJ, Lee JP. Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients. Gynecol Oncol 2005 96 : 490 495. (Pubitemid 40127153)
12. Stehman FB, Ali S, Keys HM et al. Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: Follow-up of a Gynecologic Oncology Group trial. Am J Obstet Gynecol 2007 197 : 503.e1 503.e6.
13. Cheng X, Cai SM, Li ZT et al. Concurrent chemotherapy and adjuvant extended field irradiation after radical surgery for cervical cancer patients with lymph node metastases. Int J Gynecol Cancer 2007 18 : 779 784 doi: 10.1111/j.1525-1438.2007.01088.x.
14. Monk BJ, Wang J, Im S et al. Rethinking the use of radiation and chemotherapy after radical hysterectomy: A clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial. Gynecol Oncol 2005 96 : 721 728. (Pubitemid 40255492)
15. Gray HJ. Primary management of early stage cervical cancer (IA1-IB) and appropriate selection of adjuvant therapy. J Natl Compr Canc Netw 2008 6 : 47 52. (Pubitemid 351212002)
16. Desoize B, Madoulet C. Particular aspects of platinum compounds used at present in cancer treatment. Crit Rev Oncol Hematol 2002 42 : 317 325. (Pubitemid 34615692)
17. Tanaka T, Yukawa K, Umesaki N. Radiation reduces carboplatin sensitivity and enhances nedaplatin sensitivity in cervical squamous cell carcinoma in vitro. Eur J Gynaecol Oncol 2007 28 : 352 355. (Pubitemid 47535545)
18. Sakuragi N, Satoh C, Takeda N et al. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with Stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy. Cancer 1999 85 : 1547 1554. (Pubitemid 29152827)